Home > Financial Ratios > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

BALAXI PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 10.5610.988.726.2411.72

What is the latest EV/Core EBITDA ratio of BALAXI PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of BALAXI PHARMACEUTICALS is 10.56 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202510.56
Mar202410.98
Mar20238.72
Mar20226.24
Mar202111.72

How is EV/Core EBITDA of BALAXI PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 10.56
-3.83
Mar2024 10.98
25.92
Mar2023 8.72
39.74
Mar2022 6.24
-46.76
Mar2021 11.72 -

Other Financial Ratios of BALAXI PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹91.0 Cr -6.6% -17.7% -74.4% Stock Analytics
ADANI ENTERPRISES ₹235,637.0 Cr -5.4% -16.5% -17.7% Stock Analytics
REDINGTON ₹15,698.0 Cr -7.6% -16.3% -15.5% Stock Analytics
HONASA CONSUMER ₹9,700.9 Cr 3% -2.5% 33.1% Stock Analytics
MMTC ₹8,277.0 Cr -7.7% -10.5% 3.9% Stock Analytics
LLOYDS ENTERPRISES ₹6,498.5 Cr -6% -21.2% 11.2% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-6.6%

-17.7%

-74.4%

SENSEX

-0.8%

-11.7%

-3.6%


You may also like the below Video Courses